EventsThe 2nd International Electronic Conference on Brain Sciences
Published
This submission belongs to the session 4. Molecular and Cellular Neuroscience of the event The 2nd International Electronic Conference on Brain Sciences
Published date
05 Jul, 2022
Academic Editor
author-avatarStephen Meriney
Citation
Małgorzata Kujawska, Monika Kurpik, Łukasz Witucki, Jadwiga Jodynis-Liebert, NEUROPROTECTIVE POTENTIAL OF CRANBERRY JUICE AGAINST PARKINSON'S DISEASE, in Proceedings of The 2nd International Electronic Conference on Brain Sciences, 15 July–30 July 2021, MDPI: Basel, Switzerland, doi: 10.3390/IECBS2021-10673
Share
Email
Facebook
Twitter
LinkedIn

NEUROPROTECTIVE POTENTIAL OF CRANBERRY JUICE AGAINST PARKINSON'S DISEASE

Monika Kurpik 1
Łukasz Witucki 2
image
1. Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30, 60-631 Poznań, Poland.
2. Department of Molecular Biomedicine, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland.
3. Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30, 60-631 Poznań, Poland., Poland
Abstract

Cranberry juice (CJ) is a rich source of polyphenols with strong antioxidant activity believed to contribute to this fruit's wide range of health benefits. However, to date, our knowledge of cranberry neuroprotective potential is very scarce and limited to only a few in vitro studies. Recently, we have reported that treatment of rats with CJ controls oxidative stress in several organs with the most noticeable effect in the brain. In this study, we examined the capability of cranberry juice for protection against Parkinson's disease (PD) in a rat model of parkinsonism induced by rotenone (ROT). Wistar rats were given the combined treatment with ROT and cranberry juice (CJ) (200 and 500 mg/kg/day p.o) for 35 days. To evaluate its neuroprotective effect, microscopic examination, determination of inflammation and apoptosis markers, and α-synuclein level were performed in the midbrain. Our results indicated that CJ treatment provided neuroprotection as evidenced by the enhancement of neuronal survival, which correlated well with decreased expression of pro-apoptotic proteins including caspase 9, Bax, and cytochrome c as well as declined α-synuclein level. However, the expression of tumor necrosis factor-alpha was similar across all groups with no statistically significant differences.

Keywords
Cranberry juice
Parkinson's disease
α-synuclein
apoptosis
Manuscript
Poster
NEUROPROTECTIVE POTENTIAL OF CRANBERRY JUICE AGAINST PARKINSON'S DISEASE.pdf
POMEGRANATE JUICE AMELIORATES DOPAMINE RELEASE AND MOTOR AND OLFACTORY DEFICITS IN THE ROTENONE-INDUCED RAT MODEL OF PARKINSON'S DISEASE
Diagnosis of Conditions Mimicking Neurological Disease